CML PT1 Flashcards

1
Q

Clonal hematopoietic disorders caused by genetic mutations that result in expansion, excessive production, and accumulation of mature rbc, plt, and granulocytes

A

Myeloproliferative neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DNA mutation acquires causes DNA alterations

A

Full t ancestral stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mpn affects cells in

A

common myeloid progenitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

responds strongly to growth signals

A

hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

growth factor of proliferation and differention of granulocytes and neutrophils

A

gcsf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

leukemia na di common ang accumulation of cells sa tissues

A

Aml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

leukemia na common ang accumulation sa spleen, liver, kidneys, lymph nodes, etc.

A

Cml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

notable characteristic mutations of mpn

A

cml - t(9;22)
pv - jak2v617f

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the affected cell line in cml

A

granulocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the only bcr::abl1-positive mpns

A

chronic myeloid leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the bcr::abl1-negative mpns

A

essential thrombocytopenia
polycythemia vera
primary myelofibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cml is diagnose during what phase

A

chronic phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

if cml is left untreated, what will happen

A

it will terminate acute leukemia (aml/all)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

this parameter in cml is apparent at scanning microscopy

A

leukocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sensitive and specific screening tool

A

basophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what cells are notable in the bone marrow during the chronic phase

A

pseudo-gaucher cells
sea histiocytes

17
Q

during the chronic phase it is hypercellular, with the expansion of what pool

A

granulocytic pool

18
Q

what morphologic changes in cml is decreased

A

erythropoiesis

19
Q

morphologic changes that is common in myeloproliferative involvements than in aml

A

extramedullary tissue

20
Q
  • enzyme found in the secondary granules of neutrophils
  • diff malignant from non-malignant
21
Q

Cml lap score

22
Q

Leukemoid reaction lap score

23
Q

Normal lap score

24
Q

Why is lap helpful in the differentiation of cml and leukemoid reaction

A

In terms of WBC count they are the same (increased). Leukemoid is a leukemia like reaction

25
Q

Cml pathophysiology

A

malignancy whereas leukemoid reaction is a physiologic response to severe infection

26
Q

reciprocal translocation between the long arms of chromosome 9 and 22

A

Philadelphia chromosome

27
Q

Codes for enhanced tyrosine kinase activity

A

bcr::abl1 gene

28
Q

principle of signal transduction

A

relays cells a message, and that message instructs the cell on what to do (grow, divide, stop dividing)

29
Q
  • normal bcr codes for,, and what activity
  • regulation of cell growth
A

p160
serine and threonine kinase activity

30
Q

normal abl1 codes for,, and what activity

A

p125
normal tyrosine kinase activity

31
Q

transfer phosphate from ATP going to the tyrosine

A

normal tyrosine kinase activity

32
Q

addition of phosphate and activates series of signals that will instruct the cell to proliferate, grow, differentiate, adhere, survive, or stop

A

phosphorylation

33
Q
  • formation of bcr::abl1 gene
  • codes for enhanced tyrosine kinase activity
A

Philadelphia chromosome

34
Q
  • tells the cell to grow and divide even when there is no need
  • always turned-on
  • HYPERACTIVE ENZYME
  • hypersensitive; activate signal transduction
A

tyrosine kinase

35
Q

most preferred treatment in cml

A

bone marrow and stem cell transplantation

36
Q

first line of theraphy for those who does not qualify transplantation

A

synthetic tyrosine kinase inhibitor (imatinib mesylate)

37
Q
  • targets bcr::abl1 protein
  • blocks the tyrosine kinase activity
  • reducing signal transduction activation
A

synthetic tyrosine kinase inhibitor